HOUSE BILL No. 2547
AN ACT concerning health and healthcare; relating to the regulation of certain drugs;
authorizing a school to maintain a stock supply of emergency medication kits for
certain life-threatening conditions; requiring a prescription for distribution of
emergency medication to schools; providing requirements for the administration of
emergency medication by school personnel, training; exempting certain persons from
the practice of healing arts and civil liability if acting in good faith; adding and
removing certain substances in schedules I, II, IV and V of the uniform controlled
substances act; making conforming changes to the criminal code definition of
fentanyl-related controlled substances; amending K.S.A. 21-5701, 65-1680, 65-
2872b and 72-6283 and K.S.A. 2023 Supp. 65-4105, 65-4107, 65-4111 and 65-4113
and repealing the existing sections.
Be it enacted by the Legislature of the State of Kansas:
Section 1. K.S.A. 21-5701 is hereby amended to read as follows:
21-5701. As used in K.S.A. 21-5701 through 21-5717, and amendments
thereto:
(a) "Controlled substance" means any drug, substance or
immediate precursor included in any of the schedules designated in
K.S.A. 65-4105, 65-4107, 65-4109, 65-4111 and 65-4113, and
amendments thereto.
(b) (1) "Controlled substance analog" means a substance that is
intended for human consumption, and at least one of the following:
(A) The chemical structure of the substance is substantially similar
to the chemical structure of a controlled substance listed in or added to
the schedules designated in K.S.A. 65-4105 or 65-4107, and
amendments thereto;
(B) the substance has a stimulant, depressant or hallucinogenic
effect on the central nervous system substantially similar to the
stimulant, depressant or hallucinogenic effect on the central nervous
system of a controlled substance included in the schedules designated
in K.S.A. 65-4105 or 65-4107, and amendments thereto; or
(C) with respect to a particular individual, such individual
represents or intends the substance to have a stimulant, depressant or
hallucinogenic effect on the central nervous system substantially
similar to the stimulant, depressant or hallucinogenic effect on the
central nervous system of a controlled substance included in the
schedules designated in K.S.A. 65-4105 or 65-4107, and amendments
thereto.
(2) "Controlled substance analog" does not include:
(A) A controlled substance;
(B) a substance for which there is an approved new drug
application; or
(C) a substance with respect to which an exemption is in effect for
investigational use by a particular person under section 505 of the
federal food, drug, and cosmetic act, 21 U.S.C. § 355, to the extent
conduct with respect to the substance is permitted by the exemption.
(c) "Cultivate" means the planting or promotion of growth of five
or more plants that contain or can produce controlled substances.
(d) "Distribute" means the actual, constructive or attempted
transfer from one person to another of some item whether or not there
is an agency relationship. "Distribute" includes, but is not limited to,
sale, offer for sale or any act that causes some item to be transferred
from one person to another. "Distribute" does not include acts of
administering, dispensing or prescribing a controlled substance as
authorized by the pharmacy act of the state of Kansas, the uniform
controlled substances act or otherwise authorized by law.
(e) (1) "Drug" means:
(A) Substances recognized as drugs in the official United States
pharmacopeia, official homeopathic pharmacopoeia of the United
States or official national formulary or any supplement to any of them;
(B) substances intended for use in the diagnosis, cure, mitigation,
treatment or prevention of disease in humans or animals;
(C) substances, other than food, intended to affect the structure or
any function of the body of humans or animals; and
(D) substances intended for use as a component of any article
specified in subparagraph (A), (B) or (C). HOUSE BILL No. 2547—page 2
(2) "Drug" does not include devices or their components, parts or
accessories.
(f) (1) "Drug paraphernalia" means all equipment and materials of
any kind that are used, or primarily intended or designed for use in
planting, propagating, cultivating, growing, harvesting, manufacturing,
compounding, converting, producing, processing, preparing, testing,
analyzing, packaging, repackaging, storing, containing, concealing,
injecting, ingesting, inhaling or otherwise introducing into the human
body a controlled substance and in violation of this act.
(2) "Drug paraphernalia" includes, but is not limited to:
(A) Kits used or intended for use in planting, propagating,
cultivating, growing or harvesting any species of plant that is a
controlled substance or from which a controlled substance can be
derived;
(B) kits used or intended for use in manufacturing, compounding,
converting, producing, processing or preparing controlled substances;
(C) isomerization devices used or intended for use in increasing
the potency of any species of plant that is a controlled substance;
(D) testing equipment used or intended for use in identifying or in
analyzing the strength, effectiveness or purity of controlled substances;
(E) scales and balances used or intended for use in weighing or
measuring controlled substances;
(F) diluents and adulterants, including, but not limited to, quinine
hydrochloride, mannitol, mannite, dextrose and lactose that are used or
intended for use in cutting controlled substances;
(G) separation gins and sifters used or intended for use in
removing twigs and seeds from or otherwise cleaning or refining
marijuana;
(H) blenders, bowls, containers, spoons and mixing devices used
or intended for use in compounding controlled substances;
(I) capsules, balloons, envelopes, bags and other containers used
or intended for use in packaging small quantities of controlled
substances;
(J) containers and other objects used or intended for use in storing
or concealing controlled substances;
(K) hypodermic syringes, needles and other objects used or
intended for use in parenterally injecting controlled substances into the
human body;
(L) objects used or primarily intended or designed for use in
ingesting, inhaling or otherwise introducing marijuana, cocaine,
hashish, hashish oil, phencyclidine (PCP), methamphetamine or
amphetamine into the human body, such as:
(i) Metal, wooden, acrylic, glass, stone, plastic or ceramic pipes
with or without screens, permanent screens, hashish heads or punctured
metal bowls;
(ii) water pipes, bongs or smoking pipes designed to draw smoke
through water or another cooling device;
(iii) carburetion pipes, glass or other heat-resistant tubes or any
other device used, intended to be used or designed to be used to cause
vaporization of a controlled substance for inhalation;
(iv) smoking and carburetion masks;
(v) roach clips, objects used to hold burning material, such as a
marijuana cigarette, that has become too small or too short to be held in
the hand;
(vi) miniature cocaine spoons and cocaine vials;
(vii) chamber smoking pipes;
(viii) carburetor smoking pipes;
(ix) electric smoking pipes;
(x) air-driven smoking pipes; HOUSE BILL No. 2547—page 3
(xi) chillums;
(xii) bongs;
(xiii) ice pipes or chillers;
(xiv) any smoking pipe manufactured to disguise its intended
purpose;
(xv) wired cigarette papers; or
(xvi) cocaine freebase kits.
(3) "Drug paraphernalia" does not include:
(A) Any products, chemicals or materials described in K.S.A. 21-
5709(a), and amendments thereto; or
(B) any materials used or intended for use to test a substance for
the presence of fentanyl, a fentanyl analog, ketamine or gamma
hydroxybutyric acid.
(g) "Fentanyl-related controlled substance" means any substance
designated in K.S.A. 65-4105(b)(1), (b)(2), (b)(4), (b)(10), (b)(11), (b)
(12), (b)(14), (b)(15), (b)(16), (b)(17), (b)(20), (b)(21), (b)(22), (b)(23),
(b)(24), (b)(26), (b)(27), (b)(28), (b)(35), (b)(37), (b)(41), (b)(42), (b)
(43), (b)(44), (b)(45), (b)(46), (b)(47), (b)(49) (b)(48), (b)(50), (b)(54),
(b)(55), (b)(56), (b)(57), (b)(58), (b)(59), (b)(60), (b)(61), (b)(62) (b)
(68), (b)(70), (b)(71), (b)(72), (b)(73), (b)(74), (b)(75), (b)(76), (b)(77),
(b)(78), (b)(79), (b)(80), (b)(81), (b)(82), (b)(83), (b)(84), (b)(85), (b)
(91), (b)(97), (b)(98), (b)(99), (b)(103), (b)(104), (g)(1) or (g)(2) or 65-
4107(c)(1), (c)(6), (c)(9), (c)(26), (c)(28), (c)(30), (f)(3)(A) or (f)(3)
(B), and amendments thereto, or any analog thereof.
(h) "Immediate precursor" means a substance that the state board
of pharmacy has found to be and by rules and regulations designates as
being the principal compound commonly used or produced primarily
for use and that is an immediate chemical intermediary used or likely to
be used in the manufacture of a controlled substance, the control of
which is necessary to prevent, curtail or limit manufacture.
(i) "Isomer" means all enantiomers and diastereomers.
(j) "Manufacture" means the production, preparation, propagation,
compounding, conversion or processing of or placing into pill or
capsule form a controlled substance either directly or indirectly or by
extraction from substances of natural origin or independently by means
of chemical synthesis or by a combination of extraction and chemical
synthesis. "Manufacture" does not include:
(1) The preparation or compounding of a controlled substance by
an individual for the individual's own lawful use or the preparation,
compounding, packaging or labeling of a controlled substance:
(A) By a practitioner or the practitioner's agent pursuant to a
lawful order of a practitioner as an incident to the practitioner's
administering or dispensing of a controlled substance in the course of
the practitioner's professional practice; or
(B) by a practitioner or by the practitioner's authorized agent
under such practitioner's supervision for the purpose of or as an
incident to research, teaching or chemical analysis or by a pharmacist
or medical care facility as an incident to dispensing of a controlled
substance; or
(2) the addition of diluents or adulterants, including, but not
limited to, quinine hydrochloride, mannitol, mannite, dextrose or
lactose that are intended for use in cutting a controlled substance.
(k) "Marijuana" means all parts of all varieties of the plant
Cannabis whether growing or not, the seeds thereof, the resin extracted
from any part of the plant and every compound, manufacture, salt,
derivative, mixture or preparation of the plant, its seeds or resin.
"Marijuana" does not include:
(1) The mature stalks of the plant, fiber produced from the stalks,
oil or cake made from the seeds of the plant, any other compound, HOUSE BILL No. 2547—page 4
manufacture, salt, derivative, mixture or preparation of the mature
stalks, except the resin extracted therefrom, fiber, oil or cake or the
sterilized seed of the plant that is incapable of germination;
(2) any substance listed in schedules II through V of the uniform
controlled substances act;
(3) drug products approved by the United States food and drug
administration as of the effective date of this act;
(4) cannabidiol (other trade name: 2-[(3-methyl-6-(1-
methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol); or
(5) industrial hemp as defined in K.S.A. 2-3901, and amendments
thereto, when cultivated, produced, possessed or used for activities
authorized by the commercial industrial hemp act.
(l) "Minor" means a person under 18 years of age.
(m) "Narcotic drug" means any of the following whether produced
directly or indirectly by extraction from substances of vegetable origin
or independently by means of chemical synthesis or by a combination
of extraction and chemical synthesis:
(1) Opium and opiate and any salt, compound, derivative or
preparation of opium or opiate;
(2) any salt, compound, isomer, derivative or preparation thereof
that is chemically equivalent or identical with any of the substances
referred to in paragraph (1) but not including the isoquinoline alkaloids
of opium;
(3) opium poppy and poppy straw;
(4) coca leaves and any salt, compound, derivative or preparation
of coca leaves and any salt, compound, isomer, derivative or
preparation thereof that is chemically equivalent or identical with any
of these substances, but not including decocainized coca leaves or
extractions of coca leaves that do not contain cocaine or ecgonine.
(n) "Opiate" means any substance having an addiction-forming or
addiction-sustaining liability similar to morphine or being capable of
conversion into a drug having addiction-forming or addiction-
sustaining liability. "Opiate" does not include, unless specifically
designated as controlled under K.S.A. 65-4102, and amendments
thereto, the dextrorotatory isomer of 3-methoxy-n-methylmorphinan
and its salts (dextromethorphan). "Opiate" does include its racemic and
levorotatory forms.
(o) "Opium poppy" means the plant of the species Papaver
somniferum l. except its seeds.
(p) "Person" means an individual, corporation, government or
governmental subdivision or agency, business trust, estate, trust,
partnership, association or any other legal entity.
(q) "Poppy straw" means all parts, except the seeds, of the opium
poppy, after mowing.
(r) "School property" means property upon which is located a
structure used by a unified school district or an accredited nonpublic
school for student instruction or attendance or extracurricular activities
of pupils enrolled in kindergarten or any of the grades one through 12.
This definition shall not be construed as requiring that school be in
session or that classes are actually being held at the time of the offense
or that children must be present within the structure or on the property
during the time of any alleged criminal act. If the structure or property
meets the above definition, the actual use of that structure or property at
the time alleged shall not be a defense to the crime charged or the
sentence imposed.
(s) "Simulated controlled substance" means any product that
identifies itself by a common name or slang term associated with a
controlled substance and that indicates on its label or accompanying
promotional material that the product simulates the effect of a HOUSE BILL No. 2547—page 5
controlled substance.
Sec. 2. K.S.A. 65-1680 is hereby amended to read as follows: 65-
1680. The state board of pharmacy may adopt any rules and regulations
which the board deems necessary in relation to the maintenance of
epinephrine kits under K.S.A. 72-6283, and amendments thereto. (a) A
pharmacist may distribute a stock supply of standard-dose and
pediatric-dose epinephrine auto-injectors to a school pursuant to a
prescription made pursuant to K.S.A. 72-6283, and amendments
thereto, from a physician or mid-level practitioner in the name of the
school. A pharmacist who distributes a stock supply of standard-dose
or pediatric-dose epinephrine auto-injectors to a school shall not be
liable for civil damages resulting from the administration of such
medication pursuant to this section, K.S.A. 65-2872b or 72-6283, and
amendments thereto.
(b) A pharmacist may distribute a stock supply of albuterol
metered-dose inhalers, albuterol solution and spacers to a school
pursuant to a prescription made pursuant to K.S.A. 72-6283, and
amendments thereto, from a physician or mid-level practitioner in the
name of the school. A pharmacist who distributes a stock supply of
albuterol metered-dose inhalers, albuterol solution or spacers to a
school shall not be liable for civil damages resulting from the
administration of such medication pursuant to this section, K.S.A. 65-
2872b or 72-6283, and amendments thereto.
(c) The terms used in this section mean the same as defined in
K.S.A. 72-6283, and amendments thereto.
Sec. 3. K.S.A. 65-2872b is hereby amended to read as follows: 65-
2872b. (a) The practice of the healing arts shall not be construed to
include any person administering epinephrine or albuterol in
emergency situations to a student or a member of a school staff an
individual if:
(1) (A) The person administering the epinephrine reasonably
believes that the student or staff member individual is exhibiting the
signs and symptoms of an anaphylactic reaction; or
(B) the person administering the albuterol reasonably believes
that the individual is exhibiting the signs and symptoms of respiratory
distress;
(2) a physician or mid-level practitioner, after reviewing the
school's policies and procedures, has authorized, in writing, the school
to maintain a stock supply of epinephrine emergency medication; and
(3) the epinephrine emergency medication is administered at
school, on school property or at a school-sponsored event.
(b) Any person who gratuitously and in good faith renders
emergency care or treatment, without compensation, through the
administration of epinephrine to a student or a member of a school staff
emergency medication to an individual at school, on school property or
at a school-sponsored event, and any school that employs or contracts
such person shall not be held liable for any civil damages as a result of
such care or administration or as a result of any act or failure to act in
providing or arranging further medical treatment where when the
person acts as an ordinary reasonably prudent person would have acted
under the same or similar circumstances.
(c) A physician or mid-level practitioner who writes a prescription
for emergency medication or provides training to school personnel on
the administration of emergency medication shall not be liable for civil
damages resulting from the administration of emergency medication
pursuant to this section, K.S.A. 65-1680 or 72-6283, and amendments
thereto.
(d) The terms used in this section mean the same as defined in
K.S.A. 72-6283, and amendments thereto. HOUSE BILL No. 2547—page 6
Sec. 4. K.S.A. 2023 Supp. 65-4105 is hereby amended to read as
follows: 65-4105. (a) The controlled substances listed in this section are
included in schedule I and the number set forth opposite each drug or
substance is the DEA controlled substances code that has been assigned
to it.
(b) Any of the following opiates, including their isomers, esters,
ethers, salts, and salts of isomers, esters and ethers, unless specifically
excepted, whenever the existence of these isomers, esters, ethers and
salts is possible within the specific chemical designation:
(1) Acetyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)...9821
(2) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-
phenethyl)-4-piperidinyl]-N-phenylacetamide)............9815
(3) Acetylmethadol.............................................................9601
(4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylacrylamide; acryloylfentanyl).............................9811
(5) AH-7921 (3,4-dichloro-N-[(1-
dimethylamino)cyclohexylmethyl]benzamide).............9551
(6) Allylprodine..................................................................9602
(7) Alphacetylmethadol......................................................9603
(except levo-alphacetylmethadol also known as levo-alpha-
acetylmethadol, levomethadyl acetate or LAAM)
(8) Alphameprodine............................................................9604
(9) Alphamethadol..............................................................9605
(10) Alpha′-methyl butyryl fentanyl (2-methyl-N-(1-
phenethylpiperidin-4-yl)-N-phenylbutanamide)...........9864
(11) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-
phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-
phenylethyl)-4-(N-propanilido) piperidine)..................9814
(11)(12)Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-
4-piperidinyl]-N-phenylpropanamide)..........................9832
(12)(13)Benzethidine..................................................................9606
(13)(14)Betacetylmethadol.........................................................9607
(14)(15)Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
piperidinyl]-N-phenylpropanamide).............................9830
(15)(16)Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-
hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-
phenylpropanamide)......................................................9831
(16)(17)Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-
2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide)......9836
(17)(18)Betameprodine..............................................................9608
(18)(19)Betamethadol................................................................9609
(20) Beta-methyl fentanyl (N-phenyl-N-(1-(2-
phenylpropyl)piperidin-4-yl)propionamide; also known as
β-methyl fentanyl).........................................................9856
(21) Beta'-phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N, 3-
diphenylpropanamide; also known as β'-phenyl fentanyl;
3-phenylpropanoyl fentanyl).........................................9842
(19)(22)Betaprodine...................................................................9611
(23) Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-
1,3-dihydro-2H-benzo[d]imidazol-2-one)....................9098
(20)(24)Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylbutyramide)........................................................9822
(21)(25)Clonitazene....................................................................9612
(22)(26)Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-
phenylbut-2-enamide)...................................................9844
(23)(27)Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylcyclopentanecarboxamide).................................9847
(24)(28)Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- HOUSE BILL No. 2547—page 7
phenylcyclopropanecarboxamide)................................9845
(25)(29)Dextromoramide...........................................................9613
(26)(30)Diampromide................................................................9615
(27)(31)Diethylthiambutene.......................................................9616
(28)(32)Difenoxin......................................................................9168
(29)(33)Dimenoxadol.................................................................9617
(30)(34)Dimepheptanol..............................................................9618
(31)(35)2′,5′-Dimethoxyfentanyl (N-(1-(2,5-
dimethoxyphenethyl)piperidin-4-yl)-N-
phenylpropionamide)....................................................9861
(36) Dimethylthiambutene....................................................9619
(32)(37)Dioxaphetyl butyrate.....................................................9621
(33)(38)Dipipanone....................................................................9622
(34)(39)Ethylmethylthiambutene...............................................9623
(35)(40)Etonitazene....................................................................9624
(36)(41)Etoxeridine....................................................................9625
(37)(42)Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)
(phenyl)carbamate).......................................................9851
(43) 2′-Fluoro ortho-fluorofentanyl (N-(1-(2-
fluorophenethyl)piperidin-4-yl)-N-(2-
fluorophenyl)propionamide; also known as 2′-fluoro 2-
fluorofentanyl)..............................................................9855
(44) Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylfuran-2-carboxamide).........................................9834
(38)(45)3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylfuran-3-carboxamide)........................................9860
(46) Furethidine....................................................................9626
(39)(47)Hydroxypethidine..........................................................9627
(40)(48)Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylisobutyramide)...................................................9827
(49) Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-
nitro-1H-benzimidazol-1-yl)ethan-1-amine; N,N-diethyl-2-
[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1 H-
benzimidazole-1-ethanamine).......................................9614
(41) Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylisobutyramide) ....................................................9827
(42)(50)Isovaleryl fentanyl (3-methyl- N -(1-phenethylpiperidin-4-
yl)-N-phenylbutanamide)..............................................9862
(51) Ketobemidone...............................................................9628
(43)(52)Levomoramide..............................................................9629
(44)(53)Levophenacylmorphan..................................................9631
(45)(54)Meta -Fluorofentanyl (N -(3-fluorophenyl)- N -(1-
phenethylpiperidin-4-yl)propionamide)........................9857
(55) Meta -Fluoroisobutyryl fentanyl ( N -(3-fluorophenyl)- N -
(1-phenethylpiperidin-4-yl)isobutyramide)..................9858
(56) Methoxyacetyl fentanyl (2-methoxy-N-(1-
phenethylpiperidin-4-yl)-N-phenylacetamide).............9825
(57) 4′-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)
piperidin-4-yl)-N-phenylacetamide).............................9819
(46)(58)3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-
piperidyl]-N-phenylpropanamide)................................9813
(47)(59)3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-
piperidinyl]-N-phenylpropanamide).............................9833
(60) Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-
nitro-1H-benzimidazol-1-yl)ethan-1-amine)................9757
(48)(61)Morpheridine.................................................................9632
(49) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-
phenethylpiperidin-4-yl)acetamide) ..............................9838
(50) O-desmethyltramadol HOUSE BILL No. 2547—page 8
Some trade or other names: 2-((dimethylamino)methyl-1-
(3-hydroxyphenyl)cyclohexanol;3-(2-
((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol
(51)(62)MPPP (1-methyl-4-phenyl-4-propionoxypiperidine)....9661
(52)(63)MT-45 (1-cychohexyl-4-(1,2-diphenylethyl)
piperazine).....................................................................9560
(53)(64)Noracymethadol............................................................9633
(54)(65)Norlevorphanol.............................................................9634
(55)(66)Normethadone...............................................................9635
(56)(67)Norpipanone..................................................................9636
(68) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-
phenethylpiperidin-4-yl) acetamide)............................9838
(69) O-desmethyltramadol (Some trade or other names: 2-
((dimethylamino)methyl-1-(3-hydroxyphenyl)
cyclohexanol;3-(2-((dimethylamino)methyl)-1-
hydroxycyclohexyl)phenol)
(70) Ortho-fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-
phenethylpiperidin-4-yl)acrylamide)............................9852
(71) Ortho-fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-
phenethylpiperidin-4-yl)butyramide; also known as 2-
fluorobutyryl fentanyl)..................................................9846
(57)(72)Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-
phenethylpiperidin-4-yl)propionamide;
2-fluorofentanyl)...........................................................9816
(73) Ortho -Fluorofuranyl fentanyl ( N -(2-fluorophenyl)- N -
(1-phenethylpiperidin-4-yl)furan-2-carboxamide).......9863
(74) (Ortho-fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-
phenethylpiperidin-4-yl)isobutyramide).......................9853
(75) Ortho-methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-
phenethylpiperidin-4-yl)acetamide; also known as 2-
methyl acetylfentanyl)...................................................9848
(76) Ortho-methyl methoxyacetyl fentanyl (2-methoxy-N-(2-
methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide;
also known as 2-methyl methoxyacetyl fentanyl)..........9820
(58)(77)Para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-
phenethylpiperidin-4-yl)isobutyramide).......................9826
(59)(78)Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-
phenethylpiperidin-4-yl)butyramide)............................9823
(60)(79)Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-
phenethyl)-4-piperidinyl]propanamide)........................9812
(61)(80)Para-fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-
phenethylpiperidin-4-yl)isobutyramide, 4-fluoroisobutyryl
fentanyl)........................................................................9824
(81) Para-fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-
phenethylpiperidin-4-yl)furan-2-carboxamide)............9854
(62)(82)Para-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-
(1-phenethylpiperidin-4-yl)butyramide).......................9837
(83) Para -Methoxyfuranyl fentanyl ( N -(4-methoxyphenyl)- N
-(1-phenethylpiperidin-4-yl)furan-2-carboxamide.......9859
(84) para -Methylcyclopropyl fentanyl ( N -(4-methylphenyl)- N
-(1-phenethylpiperidin-4-yl)
cyclopropanecarboxamide)..........................................9865
(85) Para-methylfentanyl (N-(4-methylphenyl)-N-(1-
phenethylpiperidin-4-yl)propionamide; also known as 4-
methylfentanyl).............................................................9817
(63)(86)PEPAP (1-(-2-phenethyl)-4-phenyl-4-
acetoxypiperidine).........................................................9663
(64)(87)Phenadoxone.................................................................9637
(65)(88)Phenampromide............................................................9638 HOUSE BILL No. 2547—page 9
(66)(89)Phenomorphan..............................................................9647
(67)(90)Phenoperidine................................................................9641
(91) Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylbenzamide; also known as benzoyl fentanyl).....9841
(68)(92)Piritramide.....................................................................9642
(69)(93)Proheptazine..................................................................9643
(70)(94)Properidine....................................................................9644
(71)(95)Propiram........................................................................9649
(72)(96)Racemoramide..............................................................9645
(73)(97)Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-
N-phenyltetrahydrofuran-2-carboxamide)....................9843
(74)(98)Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-
piperidinyl]-propanamide)............................................9835
(99) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylthiophene-2-carboxamide; also known as 2-
thiofuranyl fentanyl; thiophene fentanyl).....................9839
(75)(100)Tilidine..........................................................................9750
(76)(101)Trimeperidine................................................................9646
(77)(102)U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-
N-methylbenzamide).....................................................9547
(78)(103)Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
phenylpentanamide)......................................................9840
(104) Zipeprol (1-methoxy-3-[4-(2-methoxy-2-
phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol)......9873
(c) Any of the following opium derivatives, their salts, isomers
and salts of isomers, unless specifically excepted, whenever the
existence of these salts, isomers and salts of isomers is possible within
the specific chemical designation:
(1) Acetorphine...................................................................9319
(2) Acetyldihydrocodeine...................................................9051
(3) Benzylmorphine............................................................9052
(4) Brorphine ......................................................................9098
(5) Codeine methylbromide................................................9070
(6)(5) Codeine-N-Oxide..........................................................9053
(7)(6) Cyprenorphine...............................................................9054
(8)(7) Desomorphine...............................................................9055
(9)(8) Dihydromorphine..........................................................9145
(10)(9)Drotebanol.....................................................................9335
(11)(10)Etorphine (except hydrochloride salt)...........................9056
(12)(11)Heroin............................................................................9200
(13)(12)Hydromorphinol............................................................9301
(14)(13)Methyldesorphine..........................................................9302
(15)(14)Methyldihydromorphine...............................................9304
(16)(15)Morphine methylbromide.............................................9305
(17)(16)Morphine methylsulfonate............................................9306
(18)(17)Morphine-N-Oxide........................................................9307
(19)(18)Myrophine.....................................................................9308
(20)(19)Nicocodeine..................................................................9309
(21)(20)Nicomorphine................................................................9312
(22)(21)Normorphine.................................................................9313
(23)(22)Pholcodine.....................................................................9314
(24)(23)Thebacon.......................................................................9315
(d) Any material, compound, mixture or preparation that contains
any quantity of the following hallucinogenic substances, their salts,
isomers and salts of isomers, unless specifically excepted, whenever
the existence of these salts, isomers and salts of isomers is possible
within the specific chemical designation:
(1) Alpha-ethyltryptamine .................................................7249
Some trade or other names: etryptamine; Monase; α-ethyl- HOUSE BILL No. 2547—page 10
1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET;
and AET.
(2) 4-bromo-2,5-dimethoxy-amphetamine.........................7391
Some trade or other names: 4-bromo-2,5-dimethoxy-alpha-
methylphenethylamine; 4-bromo-2,5-DMA.
(3) 2,5-dimethoxyamphetamine..........................................7396
Some trade or other names: 2,5-dimethoxy-alpha-methyl-
phenethylamine; 2,5-DMA.
(4) 4-methoxyamphetamine................................................7411
Some trade or other names: 4-methoxy-alpha-
methylphene-thylamine; paramethoxyamphetamine; PMA.
(5) 5-methoxy-3,4-methylenedioxy-amphetamine.............7401
(6) 4-methyl-2,5-dimethoxy-amphetamine.........................7395
Some trade or other names: 4-methyl-2,5-dimethoxy-
alpha-methylphenethylamine; "DOM"; and "STP".
(7) 3,4-methylenedioxy amphetamine................................7400
(8) 3,4-methylenedioxymethamphetamine (MDMA).........7405
(9) 3,4-methylenedioxy-N-ethylamphetamine (also known as
N-ethyl-alpha-methyl-3,4 (methylenedioxy)
phenethylamine, N-ethyl MDA, MDE, and MDEA)....7404
(10) N-hydroxy-3,4-methylenedioxyamphetamine (also known
as N-hydroxy-alpha-methyl-3,4-(methylenedioxy)
phenethylamine, and N-hydroxy MDA).......................7402
(11) 3,4,5-trimethoxy amphetamine.....................................7390
(12) Bufotenine.....................................................................7433
Some trade or other names: 3-(Beta-Dimethylaminoethyl)-
5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,
N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine;
mappine.
(13) Diethyltryptamine.........................................................7434
Some trade or other names: N,N-Diethyltryptamine; DET.
(14) Dimethyltryptamine......................................................7435
Some trade or other names: DMT.
(15) Ibogaine.........................................................................7260
Some trade or other names: 7-Ethyl-6,6
Beta,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-
5H-pyrido[1',2':1,2]azepino[5,4-b]indole; Tabernanthe
iboga
(16) Lysergic acid diethylamide...........................................7315
(17) Marijuana......................................................................7360
(18) Mescaline......................................................................7381
(19) Parahexyl.......................................................................7374
Some trade or other names: 3-Hexyl-l-hydroxy-7,8,9,10-
tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran;
Synhexyl.
(20) Peyote............................................................................7415
Meaning all parts of the plant presently classified
botanically as Lophophora williamsii Lemaire, whether
growing or not, the seeds thereof, any extract from any part
of such plant, and every compound, manufacture, salts,
derivative, mixture or preparation of such plant, its seeds
or extracts.
(21) N-ethyl-3-piperidyl benzilate........................................7482
(22) N-methyl-3-piperidyl benzilate.....................................7484
(23) Psilocybin......................................................................7437
(24) Psilocyn.........................................................................7438
Some trade or other names: Psilocin.
(25) Ethylamine analog of phencyclidine.............................7455
Some trade or other names: N-ethyl-1-phenyl-cyclo- HOUSE BILL No. 2547—page 11
hexylamine; (1-phenylcyclohexyl)ethylamine; N-(1-
phenylcyclohexyl)ethylamine; cyclohexamine; PCE.
(26) Pyrrolidine analog of phencyclidine.............................7458
Some trade or other names: 1-(1-phenylcyclohexyl)-
pyrrolidine; PCPy; PHP.
(27) Thiophene analog of phencyclidine..............................7470
Some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-
piperidine; 2-thienyl analog of phencyclidine; TPCP; TCP.
(28) 1-[1-(2-thienyl)-cyclohexyl] pyrrolidine.......................7473
Some other names: TCPy.
(29) 2,5-dimethoxy-4-ethylamphetamine.............................7399
Some trade or other names: DOET.
(30) Salvia divinorum or salvinorum A; all parts of the plant
presently classified botanically as salvia divinorum,
whether growing or not, the seeds thereof, any extract from
any part of such plant, and every compound, manufacture,
salts, derivative, mixture or preparation of such plant, its
seeds or extracts.
(31) Datura stramonium, commonly known as gypsum weed or
jimson weed; all parts of the plant presently classified
botanically as datura stramonium, whether growing or not,
the seeds thereof, any extract from any part of such plant,
and every compound, manufacture, salts, derivative,
mixture or preparation of such plant, its seeds or extracts.
(32) N-benzylpiperazine .......................................................7493
Some trade or other names: BZP.
(33) 1-(3-[trifluoromethylphenyl])piperazine
Some trade or other names: TFMPP.
(34)(33)4-Bromo-2,5-dimethoxyphenethylamine......................7392
(35)(34)2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7),
its optical isomers, salts and salts of optical isomers....7348
(36)(35)Alpha-methyltryptamine (other name: AMT)...............7432
(37)(36)5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its
isomers, salts and salts of isomers................................7439
(38)(37)2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E). .7509
(39)(38)2-(2,5-Dimethoxy-4-methylphenyl)ethanamine
(2C-D)...........................................................................7508
(40)(39)2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C)7519
(41)(40)2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).....7518
(42)(41)2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine
(2C-T-2).........................................................................7385
(43)(42)2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]
ethanamine (2C-T-4).....................................................7532
(44)(43)2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)..............7517
(45)(44)2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine (2C-N). .7521
(46)(45)2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine
(2C-P)............................................................................7524
(47)(46)5–methoxy–N,N–dimethyltryptamine (5–MeO–DMT)7431
Some trade or other names: 5–methoxy–3–[2–
(dimethylamino) ethyl]indole.
(48)(47)2–(4–iodo–2,5–dimethoxyphenyl)–N–(2–
methoxybenzyl)ethanamine..........................................7538
Some trade or other names: 25I–NBOMe; 2C–I–NBOMe;
25I; Cimbi–5.
(49)(48)2–(4–chloro–2,5–dimethoxyphenyl)–N–(2–
methoxybenzyl)ethanamine..........................................7537
Some trade or other names: 25C–NBOMe; 2C–C–
NBOMe; 25C; Cimbi–82.
(50)(49)2–(4–bromo–2,5–dimethoxyphenyl)–N–(2– HOUSE BILL No. 2547—page 12
methoxybenzyl)ethanamine..........................................7536
Some trade or other names: 25B–NBOMe; 2C–B–
NBOMe; 25B; Cimbi–36.
(51)(50)2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
Some trade or other names: 25H-NBOMe.
(52)(51)2-(2,5-dimethoxy-4-methylphenyl)-N-(2-
methoxybenzyl)ethanamine
Some trade or other names: 25D-NBOMe; 2C-D-NBOMe.
(53)(52)2-(2,5-dimethoxy-4-nitrophenyl)-N-(2-
methoxybenzyl)ethanamine
Some trade or other names: 25N-NBOMe, 2C-N-NBOMe.
(54)(53)1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 H-
pyrrolo[2,3-b]pyridine-3-carboxamide (5F-CUMYL-
P7AICA).......................................................................7085
(54) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one
(other names: methoxetamine, MXE)...........................7286
(55) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other
names: para-methoxymethamphetamine, PMMA) ......1245
(e) Any material, compound, mixture or preparation that contains
any quantity of the following substances having a depressant effect on
the central nervous system, including its salts, isomers, and salts of
isomers whenever the existence of such salts, isomers, and salts of
isomers is possible within the specific chemical designation:
(1) Etizolam........................................................................2780
Some trade or other names: (4-(2-chlorophenyl)-2-ethyl-9-
methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a]
[1,4]diazepine)
(2) Mecloqualone................................................................2572
(3) Methaqualone................................................................2565
(4) Gamma hydroxybutyric acid........................................2010
(5) 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f]
[1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers,
and salts of isomers
(other name: flualprazolam).........................................2785
(6) 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f]
[1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers,
and salts of isomers (other name: clonazolam)............2786
(7) 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f]
[1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers,
and salts of isomers
(other name: flubromazolam).......................................2788
(8) 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-
benzo[e][1,4]diazepin-2-one, its salts, isomers, and salts
of isomers (other name: diclazepam)...........................2789
(f) Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture or preparation that contains
any quantity of the following substances having a stimulant effect on
the central nervous system, including its salts, isomers and salts of
isomers:
(1) Aminorex......................................................................1585
Some other names: Aminoxaphen 2-amino-5-phenyl-2-
oxazoline or 4,5-dihydro-5-phenyl-2-oxazolamine
(2) Fenethylline...................................................................1503
(3) N-ethylamphetamine.....................................................1475
(4) (+)cis-4-methylaminorex ((+)cis-4,5-dihydro-4-methyl-5-
phenyl-2-oxazolamine).................................................1590
(5) N,N-dimethylamphetamine (also known as N,N-alpha-
trimethyl-benzeneethanamine; N,N-alpha-
trimethylphenethylamine).............................................1480 HOUSE BILL No. 2547—page 13
(6) Cathinone (some other names: 2-amino-1-phenol-1-
propanone, alpha-amino propiophenone, 2-amino
propiophenone and norphedrone).................................1235
(7) Substituted cathinones
Any compound, except bupropion or compounds listed
under a different schedule, structurally derived from 2–
aminopropan–1–one by substitution at the 1-position with
either phenyl, naphthyl, or thiophene ring systems, whether
or not the compound is further modified in any of the
following ways:
(A) By substitution in the ring system to any extent with
alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide
substituents, whether or not further substituted in the ring
system by one or more other univalent substituents;
(B) by substitution at the 3-position with an acyclic alkyl
substituent;
(C)by substitution at the 2-amino nitrogen atom with alkyl,
dialkyl, benzyl, or methoxybenzyl groups; or
(D) by inclusion of the 2-amino nitrogen atom in a cyclic
structure.
(8) N-benzylpiperazine (other names: BZP,
1-benzylpiprazine)........................................................7493
(9) Methiopropamine
(N-methyl-1-(thiophen-2-yl)propan-2-amine)..............1478
(10) 4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-
methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-
methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)..........1595
(11) Amineptine (7-[(10,11-dihydro-5 H-dibenzo[a,d]
cyclohepten-5-yl)amino]heptanoic acid)......................1219
(12) Mesocarb (N-phenyl-N ′-(3-(1-phenylpropan-2-yl)-1,2,3-
oxadiazol-3-ium-5-yl)carbamimidate)..........................1227
(g) Any material, compound, mixture or preparation that contains
any quantity of the following substances:
(1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
(benzylfentanyl), its optical isomers, salts and salts of
isomers
(2) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
(thenylfentanyl), its optical isomers, salts and salts of
isomers
(3) Tianeptine, its optical isomers, salts and salts of isomers
(h) Any of the following cannabinoids, their salts, isomers and
salts of isomers, unless specifically excepted, whenever the existence of
these salts, isomers and salts of isomers is possible within the specific
chemical designation:
(1) Tetrahydrocannabinols..................................................7370
Meaning tetrahydrocannabinols naturally contained in a
plant of the genus Cannabis (cannabis plant), as well as
synthetic equivalents of the substances contained in the
plant, or in the resinous extractives of Cannabis, sp. and/or
synthetic substances, derivatives, and their isomers with
similar chemical structure and pharmacological activity
such as the following: Delta 1 cis or trans
tetrahydrocannabinol, and their optical isomers Delta 6 cis
or trans tetrahydrocannabinol, and their optical isomers
Delta 3,4 cis or trans tetrahydrocannabinol, and its optical
isomers (Since nomenclature of these substances is not
internationally standardized, compounds of these
structures, regardless of numerical designation of atomic
positions covered.), except tetrahydrocannabinols in any of HOUSE BILL No. 2547—page 14
the following:
(A) Industrial hemp, as defined in K.S.A. 2-3901, and
amendments thereto;
(B) solid waste, as defined in K.S.A. 65-3402, and
amendments thereto, and hazardous waste, as defined in
K.S.A. 65-3430, and amendments thereto, if such waste is
the result of the cultivation, production or processing of
industrial hemp, as defined in K.S.A. 2-3901, and
amendments thereto, and such waste contains a delta-9
tetrahydrocannabinol concentration of not more than 0.3%;
or
(C) hemp products, as defined in K.S.A. 2-3901, and
amendments thereto, unless otherwise deemed unlawful
pursuant to K.S.A. 2-3908, and amendments thereto.
(2) Naphthylmethylindoles
Any compound containing a 1H-indol-3-yl-(1-
naphthyl)methane structure with substitution at the
nitrogen atom of the indole group by an alkyl, haloalkyl,
cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
benzyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-
morpholinyl)ethyl group whether or not further substituted
on the indole group to any extent and whether or not
substituted on the benzyl or naphthyl ring to any extent.
(3) Naphthoylpyrroles
Any compound containing a 3-(1-naphthoyl)pyrrole
structure with substitution at the nitrogen atom of the
pyrrole group by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-
piperidinyl)methyl or 2-(4-morpholinyl)ethyl group
whether or not further substituted on the pyrrole group to
any extent, whether or not substituted on the benzyl or
naphthyl ring to any extent.
(4) Naphthylmethylindenes
Any compound containing a naphthylmethylindene
structure with substitution at the 3-position of the indene
group by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-
piperidinyl)methyl or 2-(4-morpholinyl)ethyl group
whether or not further substituted on the indene group to
any extent, whether or not substituted on the benzyl or
naphthyl ring to any extent.
(5) Cyclohexylphenols
Any compound containing a 2-(3-
hydroxycyclohexyl)phenol structure with substitution at
the 5-position of the phenolic ring by an alkyl, haloalkyl,
cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-
(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl
group whether or not substituted on the cyclohexyl ring to
any extent.
(6) 2,3-Dihydro-5-methyl-3-(4-
morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-
yl]-1-napthalenylmethanone.
Some trade or other names: WIN 55,212-2.
(7) 9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-
6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
Some trade or other names: HU-210, HU-211.
(8) Indole-3-carboxylate esters
Any compound containing a 1H-indole-3-carboxylate ester
structure with the ester oxygen bearing a naphthyl, HOUSE BILL No. 2547—page 15
quinolinyl, isoquinolinyl or adamantyl group and
substitution at the 1 position of the indole ring by an alkyl,
haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl
or 2-(4-morpholinyl)ethyl group, whether or not further
substituted on the indole ring to any extent and whether or
not substituted on the naphthyl, quinolinyl, isoquinolinyl,
adamantyl or benzyl groups to any extent.
(9) Indazole-3-carboxamides
Any compound containing a 1H-indazole-3-carboxamide
structure with substitution at the nitrogen of the
carboxamide by a naphthyl, quinolinyl, isoquinolinyl,
adamantyl, benzyl, 1-amino-1-oxoalkan-2-yl or 1-alkoxy-
1-oxoalkan-2-yl group and substitution at the 1 position of
the indazole ring by an alkyl, haloalkyl, cyanoalkyl,
alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-
methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl
group, whether or not further substituted on the indazole
ring to any extent and whether or not substituted on the
naphthyl, quinolinyl, isoquinolinyl, adamantyl, 1-amino-1-
oxoalkan-2-yl, 1-alkoxy-1-oxoalkan-2-yl or benzyl groups
to any extent.
(10) Indole-3-carboxamides
Any compound containing a 1H-indole-3-carboxamide
structure with substitution at the nitrogen of the
carboxamide by a naphthyl, quinolinyl, isoquinolinyl,
adamantyl, benzyl, 1-amino-1-oxoalkan-2-yl or 1-alkoxy-
1-oxoalkan-2-yl group and substitution at the 1 position of
the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-
piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group,
whether or not further substituted on the indole ring to any
extent and whether or not further substituted on the
naphthyl, quinolinyl, isoquinolinyl, adamantyl, 1-amino-1-
oxoalkan-2-yl, 1-alkoxy-1-oxoalkan-2-yl or benzyl groups
to any extent.
(11) (1H-indazol-3-yl)methanones
Any compound containing a (1H-indazol-3-yl)methanone
structure with the carbonyl carbon bearing a naphthyl
group and substitution at the 1 position of the indazole ring
by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl,
or 2-(4-morpholinyl)ethyl group, whether or not further
substituted on the indazole ring to any extent and whether
or not substituted on the naphthyl or benzyl groups to any
extent.
(12) (1H-indol-3-yl)methanones
Any compound containing a (1H-indol-3-yl)methanone
structure with the carbonyl carbon bearing a naphthyl,
quinolinyl, isoquinolinyl, adamantyl, phenyl, benzyl or
tetramethylcyclopropyl group and substitution at the 1
position of the indole ring by an alkyl,haloalkyl,
cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
benzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-
morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-
(N-methyl-3-morpholinyl)methyl, or
tetrahydropyranylmethyl group, whether or not further
substituted on the indole ring to any extent and whether or
not substituted on the naphthyl, quinolinyl, isoquinolinyl, HOUSE BILL No. 2547—page 16
adamantyl, phenyl, benzyl or tetramethylcyclopropyl
groups to any extent.
Sec. 5. K.S.A. 2023 Supp. 65-4107 is hereby amended to read as
follows: 65-4107. (a) The controlled substances listed in this section are
included in schedule II and the number set forth opposite each drug or
substance is the DEA controlled substances code which has been
assigned to it.
(b) Any of the following substances, except those narcotic drugs
listed in other schedules, whether produced directly or indirectly by
extraction from substances of vegetable origin or independently by
means of chemical synthesis or by combination of extraction and
chemical synthesis:
(1) Opium and opiate and any salt, compound, derivative or
preparation of opium or opiate, excluding apomorphine, thebaine-
derived butorphanol, dextrorphan, nalbuphine, naldemedine,
nalmefene, naloxegol, naloxone, 6β-naltrexol and, naltrexone and
samidorphen and their respective salts, but including the following:
(A) Raw opium....................................................................9600
(B) Opium extracts..............................................................9610
(C) Opium fluid...................................................................9620
(D) Powdered opium...........................................................9639
(E) Granulated opium..........................................................9640
(F) Tincture of opium..........................................................9630
(G) Codeine.........................................................................9050
(H) Ethylmorphine...............................................................9190
(I) Etorphine hydrochloride...............................................9059
(J) Hydrocodone.................................................................9193
(K) Hydromorphone............................................................9150
(L) Metopon........................................................................9260
(M) Morphine.......................................................................9300
(N) Noroxymorphone..........................................................9668
(O) Oxycodone....................................................................9143
(P) Oxymorphone................................................................9652
(Q) Thebaine........................................................................9333
(R) Dihydroetorphine..........................................................9334
(S) Oripavine.......................................................................9330
(2) Any salt, compound, isomer, derivative or preparation thereof
which is chemically equivalent or identical with any of the substances
referred to in paragraph (1), but not including the isoquinoline alkaloids
of opium.
(3) Opium poppy and poppy straw.
(4) Coca leaves (9040) and any salt, compound, derivative or
preparation of coca leaves, but not including decocainized coca leaves
or extractions which do not contain cocaine (9041) or ecgonine (9180).
(5) Cocaine, its salts, isomers and salts of isomers (9041).
(6) Ecgonine, its salts, isomers and salts of isomers (9180).
(7) Concentrate of poppy straw (the crude extract of poppy straw
in either liquid, solid or powder form which contains the phenanthrene
alkaloids of the opium poppy) (9670).
(c) Any of the following opiates, including their isomers, esters,
ethers, salts and salts of isomers, esters and ethers, whenever the
existence of these isomers, esters, ethers and salts is possible within the
specific chemical designation dextrorphan and levopropoxyphene
excepted:
(1) Alfentanil......................................................................9737
(2) Alphaprodine.................................................................9010
(3) Anileridine....................................................................9020
(4) Bezitramide...................................................................9800
(5) Bulk dextropropoxyphene (nondosage forms)..............9273 HOUSE BILL No. 2547—page 17
(6) Carfentanil.....................................................................9743
(7) Dihydrocodeine.............................................................9120
(8) Diphenoxylate...............................................................9170
(9) Fentanyl.........................................................................9801
(10) Isomethadone................................................................9226
(11) Levomethorphan...........................................................9210
(12) Levorphanol..................................................................9220
(13) Metazocine....................................................................9240
(14) Methadone.....................................................................9250
(15) Methadone-intermediate,4-cyano-2-dimethyl amino-4,4-
diphenyl butane.............................................................9254
(16) Moramide-intermediate, 2-methyl-3-morpholino-1,
1-diphenylpropane-carboxylic acid...............................9802
(17) Oliceridine (N-[(3-methoxythiophen-2-yl)methyl]
({2-[(9 R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-
yl]ethyl})amine fumarate).............................................9245
(18) Pethidine (meperidine)..................................................9230
(19) Pethidine-intermediate-A, 4-cyano-1-methyl-4-
phenylpiperidine............................................................9232
(20) Pethidine-intermediate-B, ethyl-4-phenyl-
piperidine-4-carboxylate...............................................9233
(21) Pethidine-intermediate-C, 1-methyl-4-phenyl-piperidine-4-
carboxylic acid..............................................................9234
(22) Phenazocine..................................................................9715
(23) Piminodine....................................................................9730
(24) Racemethorphan............................................................9732
(25) Racemorphan................................................................9733
(26) Sufentanil......................................................................9740
(27) Levo-alphacetyl methadol.............................................9648
Some other names: levo-alpha-acetyl methadol,
levomethadyl acetate or LAAM.
(28) Remifentanil..................................................................9739
(29) Tapentadol.....................................................................9780
(30) Thiafentanil...................................................................9729
(d) Any material, compound, mixture, or preparation which
contains any quantity of the following substances having a potential for
abuse associated with a stimulant effect on the central nervous system:
(1) Amphetamine, its salts, optical isomers and salts of its
optical isomers...............................................................1100
(2) Phenmetrazine and its salts...........................................1631
(3) Methamphetamine, including its salts, isomers and salts of
isomers..........................................................................1105
(4) Methylphenidate............................................................1724
(5) Lisdexamfetamine, its salts, isomers, and salts of its
isomers..........................................................................1205
(e) Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture or preparation which
contains any quantity of the following substances having a depressant
effect on the central nervous system, including its salts, isomers and
salts of isomers whenever the existence of such salts, isomers and salts
of isomers is possible within the specific chemical designation:
(1) Amobarbital..................................................................2125
(2) Glutethimide..................................................................2550
(3) Secobarbital...................................................................2315
(4) Pentobarbital.................................................................2270
(5) Phencyclidine................................................................7471
(f) Any material, compound, mixture, or preparation which
contains any quantity of the following substances:
(1) Immediate precursor to amphetamine and HOUSE BILL No. 2547—page 18
methamphetamine:
(A) Phenylacetone.........................................................8501
Some trade or other names: phenyl-2-propanone; P2P;
benzyl methyl ketone; methyl benzyl ketone.
(2) Immediate precursors to phencyclidine (PCP):
(A) 1-phenylcyclohexylamine.......................................7460
(B) 1-piperidinocyclohexanecarbonitrile (PCC)...........8603
(3) Immediate precursor to fentanyl:
(A) 4-anilino-N-phenethylpiperidine
(ANPP)..........................................................................8333
(B) N-phenyl-N-(piperidin-
4-yl)propionamide (norfentanyl)...................................8366
(g) Any material, compound, mixture or preparation which
contains any quantity of the following hallucinogenic substance, its
salts, isomers and salts of isomers, unless specifically excepted,
whenever the existence of these salts, isomers and salts of isomers is
possible within the specific chemical designation:
(1) Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an
oral solution in a drug product approved for marketing by
the United States food and drug administration............7365
(2) Nabilone........................................................................7379
[Another name for nabilone: (±)-trans-3-(1,1-
dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-
6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one]
(h) Any material, compound, mixture or preparation containing
any of the following narcotic drugs or any salts calculated as the free
anhydrous base or alkaloid, in limited quantities as set forth below:
(1) Not more than 300 milligrams of dihydrocodeinone
(hydrocodone) or any of its salts per 100 milliliters or
not more than 15 milligrams per dosage unit with a
fourfold or greater quantity of an isoquinoline alkaloid
of opium........................................................................9805
(2) Not more than 300 milligrams of dihydrocodeinone
(hydrocodone) or any of its salts per 100 milliliters or not
more than 15 milligrams per dosage unit with one or more
active, nonnarcotic ingredients in recognized therapeutic
amounts.........................................................................9806
Sec. 6. K.S.A. 2023 Supp. 65-4111 is hereby amended to read as
follows: 65-4111. (a) The controlled substances listed in this section are
included in schedule IV and the number set forth opposite each drug or
substance is the DEA controlled substances code that has been assigned
to it.
(b) Any material, compound, mixture or preparation that contains
any quantity of the following substances including its salts, isomers and
salts of isomers whenever the existence of such salts, isomers and salts
of isomers is possible within the specific chemical designation and
having a potential for abuse associated with a depressant effect on the
central nervous system:
(1) Alprazolam....................................................................2882
(2) Barbital..........................................................................2145
(3) Brexanolone..................................................................2400
(4) Bromazepam ................................................................2748
(5) Camazepam...................................................................2749
(6) Carisoprodol..................................................................8192
(7) Chloral betaine..............................................................2460
(8) Chloral hydrate..............................................................2465
(9) Chlordiazepoxide..........................................................2744
(10) Clobazam......................................................................2751
(11) Clonazepam...................................................................2737 HOUSE BILL No. 2547—page 19
(12) Clorazepate....................................................................2768
(13) Clotiazepam..................................................................2752
(14) Cloxazolam...................................................................2753
(15) Daridorexant.................................................................2410
(16) Delorazepam.................................................................2754
(16)(17) Diazepam......................................................................2765
(17)(18) Dichloralphenazone......................................................2467
(18)(19) Estazolam......................................................................2756
(19)(20) Ethchlorvynol................................................................2540
(20)(21) Ethinamate....................................................................2545
(21)(22) Ethyl loflazepate...........................................................2758
(22)(23) Fludiazepam..................................................................2759
(23)(24) Flunitrazepam................................................................2763
(24)(25) Flurazepam....................................................................2767
(25)(26) Fospropofol...................................................................2138
(26)(27) Halazepam.....................................................................2762
(27)(28) Haloxazolam................................................................2771
(28)(29) Ketazolam.....................................................................2772
(29)(30) Lemborexant.................................................................2245
(30)(31)Loprazolam...................................................................2773
(31)(32)Lorazepam.....................................................................2885
(32)(33) Lormetazepam...............................................................2774
(33)(34) Mebutamate...................................................................2800
(34)(35) Medazepam...................................................................2836
(35)(36) Meprobamate................................................................2820
(36)(37) Methohexital.................................................................2264
(37)(38) Methylphenobarbital (mephobarbital)..........................2250
(38)(39) Midazolam....................................................................2884
(39)(40) Nimetazepam................................................................2837
(40)(41) Nitrazepam....................................................................2834
(41)(42) Nordiazepam.................................................................2838
(42)(43) Oxazepam......................................................................2835
(43)(44) Oxazolam......................................................................2839
(44)(45) Paraldehyde...................................................................2585
(45)(46) Petrichloral....................................................................2591
(46)(47) Phenobarbital................................................................2285
(47)(48) Pinazepam.....................................................................2883
(48)(49) Prazepam.......................................................................2764
(49)(50) Quazepam......................................................................2881
(50)(51) Remimazolam...............................................................2846
(51)(52) Temazepam...................................................................2925
(52)(53) Tetrazepam....................................................................2886
(53)(54) Triazolam......................................................................2887
(54)(55) Zolpidem.......................................................................2783
(55)(56) Zaleplon........................................................................2781
(56)(57) Zopiclone......................................................................2784
(57) 2-[(dimethylamino)methyl]-1-(3-
methoxyphenyl)cyclohexanol, its salts, optical and
geometric isomers and salts of these isomers (including
tramadol). ......................................................................9752
(58) Alfaxalone.....................................................................2731
(59) Suvorexant....................................................................2223
(c) Any material, compound, mixture, or preparation that contains
any quantity of fenfluramine (1670), including its salts, isomers
(whether optical, position or geometric) and salts of such isomers,
whenever the existence of such salts, isomers and salts of isomers is
possible. The provisions of this subsection (c) shall expire on the date
fenfluramine and its salts and isomers are removed from schedule IV of
the federal controlled substances act (21 U.S.C. § 812; 21 code of HOUSE BILL No. 2547—page 20
federal regulations 1308.14).
(d) Any material, compound, mixture or preparation that contains
any quantity of lorcaserin (1625), including its salts, isomers and salts
of such isomers, whenever the existence of such salts, isomers and salts
of isomers is possible (21 U.S.C. § 812; 21 code of federal regulations
C.F.R. § 1308.14).
(e)(d) Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture or preparation that contains
any quantity of the following substances having a stimulant effect on
the central nervous system, including its salts, isomers (whether optical,
position or geometric) and salts of such isomers whenever the existence
of such salts, isomers and salts of isomers is possible within the
specific chemical designation:
(1) Cathine ((+)-norpseudoephedrine)................................1230
(2) Diethylpropion..............................................................1610
(3) Fencamfamin.................................................................1760
(4) Fenproporex..................................................................1575
(5) Mazindol.......................................................................1605
(6) Mefenorex.....................................................................1580
(7) Pemoline (including organometallic
complexes and chelates thereof)...................................1530
(8) Phentermine..................................................................1640
The provisions of this subsection (e)(8) (d)(8) shall expire on the
date phentermine and its salts and isomers are removed from schedule
IV of the federal controlled substances act (21 U.S.C. § 812; 21 code of
federal regulations C.F.R. § 1308.14).
(9) Pipradrol........................................................................1750
(10) Serdexmethylphenidate.................................................1729
(11) SPA((-)-1-dimethylamino-1, 2-diphenylethane)...........1635
(11)(12) Sibutramine...................................................................1675
(12)(13) Solriamfetol (2-amino-3-phenylpropyl carbamate;
benzenepropanol, beta-amino-, carbamate (ester)).......1650
(13)(14) Mondafinil.....................................................................1680
(f)(e) Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture or preparation that contains
any quantity of the following, including salts thereof:
(1) Pentazocine...................................................................9709
(2) Butorphanol (including its optical isomers)..................9720
(3) Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-
dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-
imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic
acid) (including its optical isomers) and its salts, isomers,
and salts of isomers.......................................................9725
(g)(f) Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture or preparation containing
any of the following narcotic drugs, or their salts calculated as the free
anhydrous base or alkaloid, in limited quantities as set forth below:
(1) Not more than 1 milligram of difenoxin and not less than
25 micrograms of atropine sulfate per dosage unit.......9167
(2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-
diphenyl-3-methyl-2-propion-oxybutane)....................9278
(3) 2-[(dimethylamino)methyl]-1-(3-
methoxyphenyl)cyclohexanol, its salts, optical and
geometric isomers and salts of these isomers (including
tramadol)......................................................................9752
(h)(g) Butyl nitrite and its salts, isomers, esters, ethers or their
salts.
(i)(h) The board may except by rule and regulation any compound,
mixture or preparation containing any depressant substance listed in HOUSE BILL No. 2547—page 21
subsection (b) from the application of all or any part of this act if the
compound, mixture or preparation contains one or more active
medicinal ingredients not having a depressant effect on the central
nervous system, and if the admixtures are included therein in
combinations, quantity, proportion or concentration that vitiate the
potential for abuse of the substances that have a depressant effect on
the central nervous system.
Sec. 7. K.S.A. 2023 Supp. 65-4113 is hereby amended to read as
follows: 65-4113. (a) The controlled substances or drugs, by whatever
official name, common or usual name, chemical name or brand name
designated, listed in this section are included in schedule V.
(b) Any compound, mixture or preparation containing limited
quantities of any of the following narcotic drugs which also contains
one or more nonnarcotic active medicinal ingredients in sufficient
proportion to confer upon the compound, mixture or preparation
valuable medicinal qualities other than those possessed by the narcotic
drug alone:
(1) Not more than 200 milligrams of codeine or any of its salts per
100 milliliters or per 100 grams.
(2) Not more than 100 milligrams of dihydrocodeine or any of its
salts per 100 milliliters or per 100 grams.
(3) Not more than 100 milligrams of ethylmorphine or any of its
salts per 100 milliliters or per 100 grams.
(4) Not more than 2.5 milligrams of diphenoxylate and not less
than 25 micrograms of atropine sulfate per dosage unit.
(5) Not more than 100 milligrams of opium per 100 milliliters or
per 100 grams.
(6) Not more than .5 milligram of difenoxin (9168) and not less
than 25 micrograms of atropine sulfate per dosage unit.
(c) Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture or preparation which
contains any quantity of the following substances having a stimulant
effect on the central nervous system, including its salts, isomers
(whether optical, position or geometric) and salts of such isomers
whenever the existence of such salts, isomers and salts of isomers is
possible within the specific chemical designation:
(1) Propylhexedrine (except when part of a compound used for
nasal decongestion which is authorized to be sold lawfully
over the counter without a prescription under the federal
food, drug and cosmetic act, so long as it is used only for
such purpose)................................................................8161
(2) Pyrovalerone.................................................................1485
(d) Any compound, mixture or preparation containing any
detectable quantity of ephedrine, its salts or optical isomers, or salts of
optical isomers.
(e) Any compound, mixture or preparation containing any
detectable quantity of pseudoephedrine, its salts or optical isomers, or
salts of optical isomers.
(f) Unless specifically exempted or excluded or unless listed in
another schedule, any material, compound, mixture, or preparation
which contains any quantity of the following substances having a
depressant effect on the central nervous system, including its salts:
(1) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]
butanamide) (some trade or other names BRV; UCB-
34714;
Briviact)........................................................................2710
(2) Cenobamate [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-
yl)ethyl] carbamate.......................................................2720
(3) Ezogabine N-[2-amino-4(4-fluorobenzylamino) HOUSE BILL No. 2547—page 22
-phenyl]-carbamic acid ethyl ester................................2779
(4) Ganaxolone...................................................................2401
(5) Lacosamide [(R)-2-acetoamido-N-benzyl-3
-methoxy-propionamide]..............................................2746
(5)(6) Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-
carbonyl)pyridine-2-yl-benzamide................................2790
(6)(7)Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid].....2782
Sec. 8. K.S.A. 72-6283 is hereby amended to read as follows: 72-
6283.Any accredited school may maintain an epinephrine kit. An
epinephrine kit may consist of one or more doses of epinephrine.
Epinephrine from an epinephrine kit shall be used only in emergency
situations when the person administering the epinephrine reasonably
believes that the signs and symptoms of an anaphylactic reaction are
occurring and if administered at school, on school property or at a
school-sponsored event. A school may not maintain an epinephrine kit
unless the school has consulted with a pharmacist licensed by the state
board of pharmacy. The consultant pharmacist shall have supervisory
responsibility for maintaining the epinephrine kit. The consultant
pharmacist shall be responsible for developing procedures, proper
control and accountability for the epinephrine kit. Periodic physical
inventory of the epinephrine kit shall be required. An epinephrine kit
shall be maintained under the control of the consultant pharmacist. (a)
As used in this section, K.S.A. 65-1680 and 65-2872b, and amendments
thereto:
(1) "Albuterol" means a short-acting beta-2 agonist-inhaled
medication, otherwise known as a bronchodilator, that is prescribed by
a physician or mid-level practitioner for the treatment of respiratory
distress.
(2) "Albuterol metered-dose inhaler" means a portable drug
delivery system containing a canister of multiple premeasured doses of
albuterol in a device actuator.
(3) "Albuterol solution" means a liquid form of albuterol for use
with a nebulizer.
(4) "Anaphaylaxis" or "anaphylactic reaction" means a sudden,
severe and potentially life-threatening multi-system allergic reaction.
(5) "Designated school personnel" means an employee, officer,
agent or volunteer of a school who has completed training,
documented by the school nurse, a physician or a mid-level
practitioner, to administer emergency medication on a voluntary basis
outside of the scope of employment.
(6) "Emergency medication" means epinephrine or albuterol.
(7) "Epinephrine" means a medication prescribed by a physician
or mid-level practitioner for the emergency treatment of anaphylaxis
prior to the arrival of emergency medical system responders.
(8) "Epinephrine auto-injector" means a device that automatically
injects a premeasured dose of epinephrine.
(9) "Mid-level practitioner" means the same as such term is
defined in K.S.A. 65-1626, and amendments thereto.
(10) "Nebulizer" means a device that is used to change a liquid
medication to a fine spray of liquid or mist for the administration of the
medication through inhalation.
(11) "Pharmacist" means the same as such term is defined in
K.S.A. 65-1626, and amendments thereto.
(12) "Physician" means any person licensed by the state board of
healing arts to practice medicine and surgery.
(13) "Respiratory distress" means impaired ventilation of the
respiratory system or impaired oxygenation of the blood.
(14) "School" means any school operated by a school district
organized under the laws of this state or any accredited nonpublic HOUSE BILL No. 2547—page 23
school that provides education to elementary or secondary students.
(15) "School nurse" means a registered nurse licensed by the
board of nursing to practice nursing in Kansas or a licensed practical
nurse working under a registered nurse who is employed by a school to
perform nursing services in a school setting.
(16) "Spacer" means a holding chamber that is used to optimize
the delivery of aerolized albuterol from an albuterol metered-dose
inhaler.
(17) "Stock supply" means an appropriate quantity of emergency
medication as recommended by a physician or mid-level practitioner.
(b) (1) A school may maintain a stock supply of emergency
medication upon obtaining a prescription from a physician or mid-level
practitioner in the name of the school. A physician or mid-level
practitioner shall review the school's policies and procedures
established pursuant to subsection (c) prior to prescribing such
emergency medication.
(2) A stock supply of epinephrine may consist of one or more
standard-dose or pediatric-dose epinephrine auto-injectors. A school
nurse or designated school personnel may administer such epinephrine
in an emergency situation to any individual who displays the signs and
symptoms of anaphylaxis at school, on school property or at a school-
sponsored event if such school nurse or designated school personnel
reasonably believes that an individual is exhibiting the signs and
symptoms of an anaphylactic reaction.
(3) A stock supply of albuterol may consist of one or more
albuterol metered-dose inhalers, one or more doses of albuterol
solution and one or more spacers or nebulizers. A school nurse or
designated school personnel may administer such albuterol in an
emergency situation to any individual who displays the signs and
symptoms of respiratory distress at school, on school property or at a
school-sponsored event if such school nurse or designated school
personnel reasonably believes that an individual is exhibiting the signs
and symptoms of respiratory distress.
(c) A school that maintains a stock supply of emergency
medication shall establish school policies and procedures relating to:
(1) Storage of the emergency medication, which shall require that
the emergency medication is stored:
(A) In a safe location that is readily accessible to the school nurse
or designated school personnel; and
(B) in accordance with manufacturer temperature
recommendations;
(2) periodic monitoring of the inventory and expiration dates of
emergency medication;
(3) administration of emergency medication by designated school
personnel; and
(4) training requirements for designated school personnel, which
shall be conducted by a school nurse, physician or mid-level
practitioner on not less than on an annual basis for such designated
school personnel. Such training shall include, but not be limited to, the
following:
(A) Recognition of the symptoms of anaphylaxis and respiratory
distress;
(B) administration of emergency medication;
(C) calling for emergency medical system responders;
(D) monitoring the condition of an individual after emergency
medication has been administered;
(E) notification of the parent, guardian or next of kin; and
(F) safe disposal and sanitation of used equipment.
(d) A school shall publish information related to the school's HOUSE BILL No. 2547—page 24
emergency medication policies and procedures and shall maintain
records of the training provided to designated school personnel.
(e) A school may accept monetary gifts, grants and donations to
carry out the provisions of this section or may accept epinephrine auto-
injectors, albuterol metered-dose inhalers, albuterol solution, spacers
or nebulizers from a manufacturer or wholesaler. HOUSE BILL No. 2547—page 25
Sec. 9. K.S.A. 21-5701, 65-1680, 65-2872b and 72-6283 and
K.S.A. 2023 Supp. 65-4105, 65-4107, 65-4111 and 65-4113 are hereby
repealed.
Sec. 10. This act shall take effect and be in force from and after its
publication in the statute book.
I hereby certify that the above BILL originated in the HOUSE, and was
adopted by that body
HOUSE adopted
Conference Committee Report
Speaker of the House.
Chief Clerk of the House.
Passed the SENATE
as amended
SENATE adopted
Conference Committee Report
President of the Senate.
Secretary of the Senate.
APPROVED
Governor.